DUANGDOW CUMEMANIE: Open Payments
NPI 1336102177 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 19 payments from 11 companies in 2025. Trend: 2023 $305 · 2024 $629 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $197 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Viatris Specialty LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| Pulmonx Corporation | 2 | $35 |
| GENZYME CORPORATION | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $20 |
| Insmed, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: FASENRA, YUPELRI, GLASSIA, CHARTIS CATHETER, NUCALA, TRELEGY ELLIPTA, DUPIXENT, ACTHAR.
Industry payments across FL — which companies pay providers there.
